✦ LIBER ✦

PDB8 CLINICAL BENEFITS OF PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) AND EZETIMIBE IN STATIN-TREATED TYPE-2 DIABETES PATIENTS FAILING TO REACH TARGET CHOLESTEROL LEVELS

✍ Scribed by D Liens; S Roze; WJ Valentine; ME Minshall; AJ Palmer; C Renaudin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB17 ECONOMIC ASSESSMENT OF ADD-ON THER

✍ W Berger; S Roze; AJ Palmer; WJ Valentine; D Liens; C Renaudin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCV17 PROJECTED IMPACT ON CORONARY HEART

✍ D Liens; AJ Palmer; WJ Valentine; C Renaudin; S Roze 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PDB9 PROJECTED IMPACT ON CORONARY HEART

✍ C Renaudin; S Roze; AJ Palmer; WJ Valentine; ME Minshall; D Liens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB